Short Interest in Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Decreases By 16.2%

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLFGet Free Report) saw a significant decline in short interest in February. As of February 28th, there was short interest totalling 2,282,900 shares, a decline of 16.2% from the February 13th total of 2,723,600 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 22,829.0 days.

Genomma Lab Internacional Price Performance

Genomma Lab Internacional stock remained flat at $1.43 during mid-day trading on Tuesday. The firm’s fifty day moving average is $1.36 and its 200 day moving average is $1.24. Genomma Lab Internacional has a one year low of $0.79 and a one year high of $1.43.

Genomma Lab Internacional Company Profile

(Get Free Report)

Genomma Lab Internacional, SAB. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and sexual improvement, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, and infant nutrition.

Further Reading

Receive News & Ratings for Genomma Lab Internacional Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genomma Lab Internacional and related companies with MarketBeat.com's FREE daily email newsletter.